November 2020 - Page 3 of 27

WednesdayNov 25, 2020 1:00 pm

As Global Cannabis Sales Grow 38% in 2020, Gage Cannabis Co. Expands to Offer Recreational Marijuana at Flagship Location

Research suggests cannabis sales increased 38% from 2019 to 2020 Gage expanding into fast-growing Michigan market, now offering recreational marijuana at flagship Ferndale location Adult-use cannabis revenues in Michigan projected at $1 billion per year for 2021, surpassing $1.5 billion by 2023 Quarterly sales nearly doubled to $11.9 million in Q2 2020 from $5.8 million in Q1, expected to surpass $13.1 million in Q3 Recent research published by BDSA (formerly BDS Analytics) suggests that the global cannabis industry continues to grow despite COVID-19, with forecasts predicting that 2020 sales will reach $19.7 billion - an increase of 38% from 2019 (https://ibn.fm/EkGXb).…

WednesdayNov 25, 2020 12:30 pm

Rritual Superfoods’ Extensive Distribution Network Set to Take Functional Mushrooms Mainstream

Functional Mushrooms Market Set for CAGR of 5.6% Expected to Reach $24.85 billion by 2026 Rritual Superfoods Has Launched Three Mushroom-based Products Products Boost Immune System, Brain Power and Relieve Stress Company’s Extensive Distribution Network Set to Accelerate Sales Consumers today shop for food with a number of considerations in mind, including food safety and the health benefits of their selected grocery items. This has resulted in increased demand for functional foods, with one sector — functional mushrooms — projected to increase at a CAGR of 5.6% during 2021–2026. This would put the market for functional mushrooms at $24.85 billion…

WednesdayNov 25, 2020 12:25 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Therapeutics Solution to Employees of Fortune 500 Company

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on Jan. 1, 2021, with the beginning of a new benefits year, calls for Dario to provide its digital diabetes tools and coaching to employees and their dependents. “We believe that employees will benefit from Dario's unique therapeutic approach, which delivers adaptive, personalized experiences designed to drive behavior change through intuitive, clinically proven digital tools and coaching,” said DarioHealth president and North America GM Rick Anderson…

WednesdayNov 25, 2020 12:00 pm

Knightscope, Inc. Reimagines Public Safety Across the U.S. Through Autonomous Security Capabilities

Violent crimes in the U.S. occur every 24.6 seconds, and property crime occurs every 4.1 seconds There are over 320 million people in the U.S., with only two million+ law enforcement and security professionals to protect them Knightscope’s autonomous security robots are currently in operation across five U.S. time zones, with over one million hours in the field The K1 is an award-winning ASR whose achievements were recognized with the 2018 Security Today New Product of the Year Knightscope, a leader in the development of autonomous security capabilities, is reimagining public safety to make the United States the safest country…

WednesdayNov 25, 2020 11:33 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president of investor and public communications. The company also plans to announce additional board members coming from key business and science segments. Current board members who are remaining include Dr. Roger McIntyre, chair and CEO; Bill Wilkerson, vice…

WednesdayNov 25, 2020 11:30 am

Pure Extracts Technologies Corp. (CSE: PULL) Strengthens Oil Extraction Business, Ventures into Functional Mushroom Space

Pure Extracts carried out its initial oil extraction, distillation trials in early November, plans to commence extraction tolling services in December Once Sales License is obtained from Health Canada, the Company plans to begin marketing its own ‘Pure Pulls’ branded cannabis derived product range Pure Extracts will simultaneously seek to market Company’s white-labelling prowess, offering oil extraction capabilities to Licensed Producers currently operating in cannabis space Company also announced its interest in joining functional mushroom sector, with its first products set to be launched in 1Q2021 Separately, Pure Extracts named Dwight Duncan to its Board of Directors Pure Extracts Technologies…

WednesdayNov 25, 2020 11:00 am

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Sells 15 Streamway(R) Systems in Q3 2020 as COVID-era Drives Need for Sanitation Systems

Closed design of Streamway(R) System provides safety from potential hazards of drips and spills during endoscopy, radiology, cystoscopy, urology procedures The Streamway(R) System reduces costs, minimizes environmental impact of 50 million potentially disease-infected canisters disposed into landfills POAI’s Skyline Medical sells 8 Streamway(R) Systems to large university hospital in Virginia, 15 sold halfway into Q3 2020 In the age of COVID-19, the need for sanitation and safety during hospital procedures has reached an all-time high. Health professionals have reported an inhibited level of performance due to a lack of protection, comfort, and increased fatigue during surgery (https://ibn.fm/87UEr). Sanitary disposal systems,…

WednesdayNov 25, 2020 10:45 am

AzurRx BioPharma Inc. (NASDAQ: AZRX) Planning to Test Immediate Release MS1819 Capsules in Cystic Fibrosis Study

The company plans to add another study arm to its ongoing Phase 2b OPTION 2 clinical study which currently tests delayed release capsules If it receives FDA approval, AzurRx would be able to identify the optimal delivery method for its drug candidate MS1819 without significant extra costs or delays Enrollment in this arm of the study could begin as early as December 2020 AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, has submitted a protocol amendment request to the U.S. Food and Drug Administration that would allow it to test immediate…

WednesdayNov 25, 2020 10:31 am

QualityStocksNewsBreaks – Knightscope Inc. Announces Continued Engagement of InvestorBrandNetwork, Interview with LD Micro

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), on Tuesday announced it will continue to utilize the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. As part of the client-partner relationship, IBN will leverage its investor-based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for Knightscope. “Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of…

WednesdayNov 25, 2020 10:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) IND Application for Cancer Drug Berubicin Accepted for Review

CNS Pharmaceuticals wants to obtain FDA authorization for an Investigational New Drug application for drug candidate Berubicin, a novel treatment for Glioblastoma Multiforme Company believes it’s on track to start in Q1 2021 a potentially pivotal Phase II Berubicin trial with adult GBM patients who have failed their primary treatment for the disease Separately, a Phase II adult trial and a first-ever Phase I pediatric trial are slated to begin in 2021 in Poland in collaboration with sub-licensee partner, WPD Pharmaceuticals Members of CNS’s management team attended A.G.P.’s Virtual Health Symposium, meeting 1-on-1 with investors CNS Pharmaceuticals (NASDAQ: CNSP), a…

Site Search

Company Search

Month: November 2020